InnoCare Pharma Limited (HKG:9969)
Hong Kong
· Delayed Price · Currency is HKD 11.78
+0.34 (2.97%)
Jun 6, 2025, 4:08 PM HKT
InnoCare Pharma Revenue
InnoCare Pharma had revenue of 381.26M CNY in the quarter ending March 31, 2025, with 129.92% growth. This brings the company's revenue in the last twelve months to 1.22B, up 71.32% year-over-year. In the year 2024, InnoCare Pharma had annual revenue of 1.01B with 36.68% growth.
Revenue (ttm)
1.22B CNY
Revenue Growth
+71.32%
P/S Ratio
18.84
Revenue / Employee
1.12M CNY
Employees
1,089
Market Cap
24.74B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| CSPC Pharmaceutical Group | 28.99B |
| WuXi Biologics | 19.87B |
| Sino Biopharmaceutical | 30.72B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |